Liberis Limited – Trademark Portfolio
Entity Type: 99
Liberis Limited holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 3 are pending. Notable registered marks include L and LIBERIS.
Scale Space, 58 Wood Lane
London W12 7RZ
Showing of trademarks Trademarks
Trademark Classifications
Liberis Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Liberis Limited have?
Liberis Limited has 15 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 pending, 9 abandoned.
What trademark classes does Liberis Limited file in?
Liberis Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Liberis Limited's most well-known trademarks?
Liberis Limited's registered trademark portfolio includes well-known marks such as L and LIBERIS. These are among 3 currently registered trademarks in the portfolio.
What is Liberis Limited's trademark registration success rate?
Liberis Limited has a 25% trademark registration rate, with 3 out of 12 resolved applications resulting in successful registration. Currently, 3 applications are pending review.